InsidersTradesSigma
Follow the Cartesian Therapeutics, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €267.5m. The latest transaction was disclosed on 9 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SPRINGER TIMOTHY A. All data is free.
95
Insider Decl.
n/a
Thresholds
€2m
11 ops.
Buy Volume
€620,378
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cartesian Therapeutics, Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$34.57.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2026
Declarations95 total
35,038 shares@ US$6.64210.091% mcap100.0% of flowCommonSEC144:0001950047-26-005808
3,924 shares@ US$6.410.0097% mcap9.7% of flowCommonSEC144:0001950047-26-005471
758,001 sharesCommon StockSEC:0002064832-26-000148:0
758,001 sharesCommon StockSEC:0002064832-26-000149:0
6,555 shares0Common StockSEC:0001453687-26-000066:0
23,766 shares@ US$6.819736.0% of flowCommon StockSEC:0001453687-26-000047:0
3,573 shares@ US$6.819714.5% of flowCommon StockSEC:0001453687-26-000046:0
10,591 shares@ US$6.819748.9% of flowCommon StockSEC:0001453687-26-000045:0
2,600 shares0Common StockSEC:0001453687-26-000039:0
143,200 shares0Common StockSEC:0001453687-26-000038:0
2,600 shares0Common StockSEC:0001453687-26-000037:0
27,000 shares0Common StockSEC:0001453687-26-000036:0
2,600 shares0Common StockSEC:0001453687-26-000035:0
6,500 shares0Common StockSEC:0001453687-26-000034:0
37,000 shares0Common StockSEC:0001453687-26-000033:0
2,600 shares0Common StockSEC:0001453687-26-000032:0
24,000 shares0Common StockSEC:0001453687-26-000031:0
2,600 shares0Common StockSEC:0001453687-26-000030:0
2,600 shares0Common StockSEC:0001453687-26-000029:0
2,600 shares0Common StockSEC:0001453687-26-000028:0
7,500 shares@ US$3.3016.8% of flowCommon StockSEC:0001453687-26-000002:0
5,800 shares0Common StockSEC:0001453687-25-000144:0
30,000 shares@ US$6.859966.9% of flowCommon StockSEC:0001453687-25-000132:0
Canonical exit: 4 Mar 2026 (T+90)
7,500 shares@ US$3.3020.4% of flowCommon StockSEC:0001453687-25-000130:0
20,000 shares0Common StockSEC:0001453687-25-000127:0
25 of 95 declarations
Acerca de Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias basadas en ARN para enfermedades graves. Cotiza en NASDAQ bajo el ticker XNAS.